Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer
Clinical trial NCT00543842 · COMPLETED
Trial details
- NCT number
- NCT00543842
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2013-12-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.